Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Soufflé Therapeutics has potent, precise, and safe medicines can be designed and developed for all diseases.
Hello Sunshine is a media company that is dedicated to female authorship across all storytelling platforms.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.
AN2 Therapeutics develops small-molecule medicines from boron chemistry for infectious diseases, hematologic disorders, and oncology.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.
LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.
Jia provides blockchain-based financing to businesses in emerging markets and delivers returns on real-world assets to investors.
Premier Lacrosse League is a proposed professional lacrosse league.
Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Adcendo is a biotech company that develops antibody-drug conjugates (ADCs) to target cancers with high unmet medical needs.
Real Sports App is a social sports data platform that engages fans around every live sports moment.
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
TCG has invested in 153 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG's top investment sectors include Biotechnology, Therapeutics, Pharmaceutical, Health Care, Medical. The firm invests across 26 different industry categories.
Among tracked funding rounds, Mirum Pharmaceuticals received $600.0M in a Post-IPO Debt round. TCG's total known invested capital is $1.8B.
TCG's average investment size is $24.7M across its portfolio of 153 companies.
Recent TCG portfolio additions include Aclaris Therapeutics, Disc Medicine, Alector, Soufflé Therapeutics, Hello Sunshine. These companies were founded in 2020 or later.